The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Open accessAbstract
T(H)17 lymphocytes appear to be essential in the pathogenesis of numerous inflammatory diseases. We demonstrate here the expression of IL-17 and IL-22 receptors on blood-brain barrier endothelial cells (BBB-ECs) in multiple sclerosis lesions, and show that IL-17 and IL-22 disrupt BBB tight junctions in vitro and in vivo. Furthermore, T(H)17 lymphocytes transmigrate efficiently across BBB-ECs, highly express granzyme B, kill human neurons and promote central nervous system inflammation through CD4+ lymphocyte recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In turn, IL-17 further impairs BBB integrity, thus allowing more immune cells and cytokines to gain easy access to the CNS [65, 66].”
From Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain (2022) · cites this paper as [66]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“IL-17 impairs blood–brain barrier integrity, allowing for more immune cells to cross into the CNS [127,128].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [128]
The cited source says what the claim attributes to it.
In the citing paper
“a subset of CD4+ T cells that is a major contributor to the pathogenicity of several inflammatory and autoimmune conditions (9–11)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“inflammatory subtypes of T cells, particularly Th17 cells, are clearly deleterious in diseases such as multiple sclerosis (9–11, 24)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Th17 cells are deleterious to the CNS”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
Steinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis
Bettelli, E., Sullivan, B., Szabo, S. J., Sobel, R. A., Glimcher, L. H., & Kuchroo, V. K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031819 · Cited by 488
Wosik, K., Cayrol, R., Dodelet-Devillers, A., Berthelet, F., Bernard, M., Moumdjian, R., Bouthillier, A., Reudelhuber, T. L., & Prat, A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2088-07.2007 · Cited by 259
Self-citationExpression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes
Chung, Y., Yang, X., Chang, S. H., Ma, L., Tian, Q., & Dong, C. (2006) · Cell Research · doi:10.1038/sj.cr.7310106 · Cited by 231
Cited by
Items 301–400 of 1,003
Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10
Zhang, Y., Gao, Z., Wang, D., Zhang, T., Sun, B., Mu, L., Wang, J., Liu, Y., Kong, Q., Liu, X., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-79 · Cited by 115
“Permeability assays were conducted as previously described [19].”
Methodvan Noort, J. M., Bsibsi, M., Gerritsen, W. H., van der Valk, P., Bajramovic, J. J., Steinman, L., & Amor, S. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181e4939c · Cited by 112
“Tumor necrosis factor and IL-17 are known to play important roles in mediating blood-brain barrier activation, and CCL5 and CCL1 mediate recruitment of leukocytes, including memory T cells and plasma cells (32, 33).”
BackgroundPatrick, K. L., Bell, S. L., Weindel, C. G., & Watson, R. O. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00138 · Cited by 110
“The exact mechanism by which T cell populations or monocytes initially gain access to the brain is not well understood, but evidence points to roles IL-17 and IL-22 via breakdown of the BBB and modulation of resident immune cells of the brain (Kebir et al., 2007).”
BackgroundSubramaniam, K. S., Datta, K., Quintero, E. A., Manix, C., Marks, M. S., & Pirofski, L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901638 · Cited by 124
“Hence, compared with control mice, higher levels of C5a in sIgM2/2mice could have inhibited phagocytosis, compounding the effect of IgM deficiency, and enhanced inflammatory damage in the brain, favoring C. neoformans dissemination and BBB disruption.”
BackgroundInfluentialMeng, J., Banerjee, S., Li, D., Sindberg, G. M., Wang, F., Ma, J., & Roy, S. (2015) · Scientific Reports · doi:10.1038/srep10918 · Cited by 113
Sirtuins in Neuroendocrine Regulation and Neurological Diseases
Fujita, Y., & Yamashita, T. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00778 · Cited by 118
“The transcription factor, RAR-related orphan receptor γ-t (RORγt), regulates Th17 cell differentiation (Ivanov et al., 2006; Kebir et al., 2007).”
BackgroundNuanced roles of cytokines in three major human brain disorders
Steinman, L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36532 · Cited by 119
Platt, M. P., Agalliu, D., & Cutforth, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00442 · Cited by 108
Paintlia, M. K., Paintlia, A. S., Singh, A. K., & Singh, I. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07136.x · Cited by 120
“Recent studies document that Th17 cells migrate preferentially across the blood–brain barrier and that secreted IL-17 participates in inflammation and lesion formation in MS brain (Kebir et al. 2007).”
BackgroundInterleukin-22 is increased in multiple sclerosis patients and targets astrocytes
Perriard, G., Mathias, A., Enz, L., Canales, M., Schluep, M., Gentner, M., Schaeren‐Wiemers, N., & Pasquier, R. D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0335-3 · Cited by 119
“ing an expression of this receptor by endothelial cells [22]; but in our hands, this expression was restricted to the brain of non-MS patients and in the NAWM of one MS”
Multiple Sclerosis and Obesity: Possible Roles of Adipokines
Guerrero-García, J. D. J., Carrera-Quintanar, L., López-Roa, R. I., Márquez-Aguirre, A. L., Rojas-Mayorquín, A. E., & Ortuño‐Sahagún, D. (2016) · Mediators of Inflammation · doi:10.1155/2016/4036232 · Cited by 123
“BecauseTh17promotes BBBdisruption and causes the increase of CD4+ T cell infiltration in the CNS [158], the presence of Th17 cells in the CNS is able to give rise tomicroglial activation and the increase of the proinflammatory cytokine microenvironment [47].”
BackgroundSansores‐España, L. D., Melgar‐Rodríguez, S., Sagredo-Olivares, K., Cafferata, E. A., Martínez-Aguilar, V. M., Vernal, R., Paula-Lima, A. C., & Díaz‐Zúñiga, J. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.781582 · Cited by 118
“IL: interleukin, TNF: tumor necrosis factor, MMP: matrix metalloproteinases, BBB: blood-brain barrier, LPS: lipopolysaccharide, TLRs: toll-like receptors, CDs: cluster of differentiation, TRPV1: transient receptor potential cation channel V1, NF-κB: nuclear factor κ B, NFTs: neurofibrillary tangles, TCR: T-cell recept…”
BackgroundInfluentialDaskalakis, N. P., Cohen, H., Nievergelt, C. M., Baker, D. G., Buxbaum, J. D., Russo, S. J., & Yehuda, R. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.07.024 · Cited by 105
“Additionally, in situations of peripheral or central inflammation the permeability of the blood-brain barrier is increased allowing the entry of peripheral immunemediators in the brain (Kebir et al., 2007).”
The role of Th17 cells in auto-inflammatory neurological disorders
Tahmasebinia, F., & Pourgholaminejad, A. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.023 · Cited by 122
“These cytokines bind to their receptors that expressed in endothelial cells of BBB and help Th17 cells to infiltrate into the brain in inflammatory diseases (Figure 2) (Kebir et al. , 2007).”
BackgroundThe Emerging Role of Autoimmunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/cfs)
Morris, G., Berk, M., Gałecki, P., & Maes, M. H. J. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8553-0 · Cited by 118
The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients
Ma, J., Yu, J., Tao, X., Cai, L., Wang, J., & Zheng, S. G. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1510-7 · Cited by 107
IL-22: There Is a Gap in Our Knowledge
Zenewicz, L. A. (2018) · ImmunoHorizons · doi:10.4049/immunohorizons.1800006 · Cited by 107
“Studies have also examined how IL-22may synergize with other cytokines, especially IL-17 and/or IFN-g, tomodulate target cell function (55, 56).”
BackgroundLückel, C., Picard, F. S. R., Raifer, H., Carrascosa, L. C., Guralnik, A., Zhang, Y., Klein, M., Bittner, S., Steffen, F., Moos, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13731-z · Cited by 113
Autoimmune Neuroinflammatory Diseases: Role of Interleukins
Khan, A. W., Farooq, M., Hwang, M.-J., Haseeb, M., & Choi, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097960 · Cited by 119
“IL-22, together with IL-17, weakens the integrity of the blood-brain barrier and allows lymphocytes to enter the CNS, increasing the severity of MS [40].”
BackgroundInterleukin-17 in Various Ocular Surface Inflammatory Diseases
Kang, M. H., Kim, M. K., Lee, H. J., Lee, H. I., Wee, W. R., & Lee, J. H. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.7.938 · Cited by 118
“Since a distinct T cell subset, known as T helper type 17 lymphocyte (Th-17), which is characterized by the production of interleukin (IL)-17 has been identified (1, 2), compelling evidence has accumulated that Th-17 cells are involved in a wide variety of autoimmune (3-8) and allergic diseases (9) and transplantation…”
BackgroundNeurons as targets for T cells in the nervous system
Liblau, R., Gonzalez‐Dunia, D., Wiendl, H., & Zipp, F. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.008 · Cited by 120
IL‐22 and inflammation: Leukin' through a glass onion
Zenewicz, L. A., & Flavell, R. A. (2008) · European Journal of Immunology · doi:10.1002/eji.200838655 · Cited by 114
IL-22, cell regeneration and autoimmunity
Nikoopour, E., Bellemore, S. M., & Singh, B. (2014) · Cytokine · doi:10.1016/j.cyto.2014.09.007 · Cited by 112
Imler, T. J., & Petro, T. M. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.10.015 · Cited by 104
Drug delivery strategies for the treatment of malignant gliomas
Allhenn, D., Boushehri, M. A. S., & Lamprecht, A. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.06.025 · Cited by 106
Sonobe, Y., Takeuchi, H., Kataoka, K., Li, H., Jin, S., Mimuro, M., Hashizume, Y., Sano, Y., Kanda, T., Mizuno, T., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025940 · Cited by 103
Dithmer, S., Blasig, I. E., Fraser, P. A., Qin, Z., & Haseloff, R. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115601 · Cited by 109
Jones, B. E., Tovar, K. R., Goehring, A. S., Jalali‐Yazdi, F., Okada, N. J., Gouaux, E., & Westbrook, G. L. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw0044 · Cited by 109
The role of Th17 cells/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A
Fu, J., Huang, Y., Bao, T., Liu, C., Liu, X., & Chen, X. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02446-6 · Cited by 107
“In the cell model, Th17 cells were proved to cross the BBB, and the presence of Th17 cells in the lesions of CNS was related to enhanced neuroinflammation [56].”
BackgroundJun, L., Xu, W., Zhang, Z. W., Huang, H., Zhang, L. M., & Zhou, J. (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00294.x · Cited by 100
“Kebir and colleagues recently reported that human Th17 cells can disrupt BBB tight junctions via direct effects of IL-17A and IL-22 on endothelial cells (Kebir et al., 2007).”
BackgroundTroletti, C. D., de Goede, P., Kamermans, A., & de Vries, H. E. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.010 · Cited by 106
Li, H., Nourbakhsh, B., Cullimore, M. L., Zhang, G., & Rostami, A. M. (2011) · European Journal of Immunology · doi:10.1002/eji.201041125 · Cited by 103
Muñoz-Jurado, A., Escribano, B. M., Caballero‐Villarraso, J., Galván, A., Agüera, E., Santamaría, A., & Túnez, I. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01011-0 · Cited by 107
Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma
Akintunde, M. E., Rose, M., Krakowiak, P., Heuer, L., Ashwood, P., Hansen, R., Hertz-Picciotto, I., & Van de Water, J. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.07.003 · Cited by 96
“1 1 10 100 1000 10000 IL -1 7 pg /m l ∗ ∗ 0.1 1 10 100 1000 10000 IL -4 p g / m l ASD+ ASD- TD+ TD- ASD+ ASD- TD+ TD- 0.01 0.1 1 10 100 1000 10000 100000 IL -1 3 pg /m l * * A B C on the central nervous system (CNS) endothelial cells (Kebir et al., 2007).”
InfluentialInterleukin-17 inhibits Adult Hippocampal Neurogenesis
Liu, Q., Xin, W., He, P., Turner, D., Yin, J., Gan, Y. X., Shi, F., & Wu, J. (2014) · Scientific Reports · doi:10.1038/srep07554 · Cited by 102
An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells
Aschenbrenner, D., Foglierini, M., Jarrossay, D., Hu, D., Weiner, H. L., Kuchroo, V. K., Lanzavecchia, A., Notarbartolo, S., & Sallusto, F. (2018) · Nature Immunology · doi:10.1038/s41590-018-0200-5 · Cited by 104
Bain, K. A., McDonald, E., Moffat, F., Tutino, M., Castelino, M., Barton, A. C., Cavanagh, J., Ijaz, U. Z., Siebert, S., McInnes, I. B., et al. (2019) · British Journal of Dermatology · doi:10.1111/bjd.18008 · Cited by 113
Immune modulation after traumatic brain injury
Bouras, M., Asehnoune, K., & Roquilly, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.995044 · Cited by 107
“Th17 cells promote cell migration across the BBB in some neuroinflammatory disease (160).”
BackgroundA pro-inflammatory role for Th22 cells in Helicobacter pylori -associated gastritis
Zhuang, Y., Cheng, P., Liu, X.-F., Peng, L., Li, B., Wang, T., Chen, N., Li, W., Shi, Y., Chen, W., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-307020 · Cited by 99
Role of Regulatory T Cells in Pathogenesis and Biological Therapy of Multiple Sclerosis
Buc, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/963748 · Cited by 114
“They produced various cytokines, especially IL-17 and they themselves killed human neurons and promoted central nervous system inflammation through CD4 lymphocyte recruitment [23, 33, 34].”
BackgroundJumah, M. A., & Abumaree, M. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13079298 · Cited by 108
Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain
Peng, Z., Peng, S., Lin, K., Zhao, B., Wei, L., Tuo, Q., Liao, D., Yuan, T., & Shi, Z. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02543-6 · Cited by 95
“In turn, IL-17 further impairs BBB integrity, thus allowing more immune cells and cytokines to gain easy access to the CNS [65, 66].”
BackgroundNF-κB, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis
Yan, J., & Greer, J. M. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708787122941 · Cited by 106
“cells are important in the initiation of episodes of demyelination in the relapsing-remitting phase of MS [3, 18-24].”
BackgroundAnimal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases
de Souza, J. M., Gonçalves, B. D. C., Gomez, M. V., Vieira, L. B., & Ribeiro, F. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00145 · Cited by 101
“MS is often described as a T cell-mediated disease, as a common MS feature is that Th-17 CD4+ cells cross the BBB and cause neuronal damage such as axon demyelination and neuronal cell death (Kebir et al., 2007).”
BackgroundTroletti, C. D., Fontijn, R. D., Gowing, E., Charabati, M., Hof, B. V. H., Didouh, I., van der Pol, S. M. A., Geerts, D., Prat, A., van Horssen, J., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1294-2 · Cited by 102
Self-citationNovel Galectin-3 Roles in Neurogenesis, Inflammation and Neurological Diseases
Soares, L. C., Al‐Dalahmah, O., Hillis, J. M., Young, C. C., Asbed, I., Sakaguchi, M., O’Neill, E. E., & Szele, F. G. (2021) · Cells · doi:10.3390/cells10113047 · Cited by 101
Th17 cells in autoimmune demyelinating disease
Segal, B. M. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0186-z · Cited by 103
Wang, X., Li, G., Guo, J., Zhang, Z., Zhang, S., Zhu, Y., Cheng, J., Yu, L., Ji, Y., & Tao, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01393 · Cited by 105
“It might be induced by the increase of inflammatory interleukin-17 (IL-17), which is produced from activated Th17 cells (Kebir et al., 2007; Peelen et al., 2011).”
BackgroundEngineered Living Materials for Advanced Diseases Therapy
Xue, D. Q., Wu, W. H., Pan, P., & Zhang, X. (2023) · Advanced Materials · doi:10.1002/adma.202304963 · Cited by 102
Setiadi, A. F., Abbas, A. R., Jeet, S., Wong, K., Bischof, A., Peng, I., Lee, J., Bremer, M. C. D., Eggers, E. L., DeVoss, J., et al. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.04.011 · Cited by 92
Denieffe, S., Kelly, R. J., McDonald, C., Lyons, A., & Lynch, M. A. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.07.174 · Cited by 101
“Expression of tight junction proteins, including claudin 5, is decreased by inflammatory cytokines like TNF-a and IL-1b which are released from activated microglia (Kebir et al., 2007; Walsh et al., 2000).”
BackgroundCosentino, M., & Marino, F. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9410-z · Cited by 97
“…MS include Th1 cells secreting proinflammatory type-1 cytokines such as tumor necrosis factor-α, and interferon (IFN)-γ (Hauser and Oksenberg 2006; Hemmer et al. 2006; Lassmann and Ransohoff 2004) and Th17 cells producing the proinflammatory cytokine IL-17 (Tzartos et al. 2008; Kebir et al. 2007).”
BackgroundCD4+ T cells mediate cytotoxicity in neurodegenerative diseases
Appel, S. H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci38096 · Cited by 96
Towards Retinoid Therapy for Alzheimers Disease
Shudo, K., Fukasawa, H., Nakagomi, M., & Yamagata, N. (2009) · Current Alzheimer Research · doi:10.2174/156720509788486581 · Cited by 91
“The importance of Th17 cells in central nervous system inflammation in MS patients and experimental autoimmune myasthenia gravis in C57BL/6 mice has been shown [75, 76].”
BackgroundTamibarotene: A Candidate Retinoid Drug for Alzheimer’s Disease
Fukasawa, H., Nakagomi, M., Yamagata, N., Katsuki, H., Kawahara, K., Kitaoka, K., Miki, T., & Shudo, K. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00314 · Cited by 91
Cho, J. J., Xu, Z., Parthasarathy, U., Drashansky, T. T., Helm, E. Y., Zuniga, A. N., Lorentsen, K. J., Mansouri, S., Cho, J. Y., Edelmann, M. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08605-3 · Cited by 98
Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases
Chen, H., Wang, J., Zhang, C., Ding, P., Shuxia, T., Chen, J., Ji, G., & Wu, T. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113341 · Cited by 96
Ayimba, E., Hegewald, J., Ségbéna, A., Gantin, R. G., Lechner, C. J., Agossou, A., Banla, M., & Soboslay, P. T. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04474.x · Cited by 96
Complement regulator factor H as a serum biomarker of multiple sclerosis disease state
Ingram, G., Hakobyan, S., Hirst, C. L., Harris, C. L., Pickersgill, T. P., Cossburn, M., Loveless, S., Robertson, N. P., & Morgan, B. P. (2010) · Brain · doi:10.1093/brain/awq085 · Cited by 96
“At initiation of the pathological process, multiple sclerosis is driven by the adaptive immune response, with antigen primed T cells migrating into the CSF where T helper 1 and 17 cells release pro-inflammatory cytokines to mount an inflammatory attack (Gocke et al., 2007; Kebir et al., 2007; McFarland and Martin, 200…”
Targeting the development and effector functions of TH17 cells
Ghilardi, N., & Ouyang, W. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.016 · Cited by 106
Th17 cells in central nervous system autoimmunity
Sie, C., Korn, T., & Mitsdoerffer, M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.03.009 · Cited by 100
DEL-1-Regulated Immune Plasticity and Inflammatory Disorders
Hajishengallis, G., & Chavakis, T. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.02.010 · Cited by 93
“IL-17 can promote disruption of the blood-brain-barrier and increase endothelial permeability [55,56]; hence the upregulation of IL-17 in DEL-1 deficiency provides a potential mechanism for the disrupted barrier in DEL-1-deficient mice.”
BackgroundMcCandless, E. E., Budde, M. D., Lees, J. R., Dorsey, D. A., Lyng, E., & Klein, R. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802258 · Cited by 99
Activation of mixed glia by Aβ-specific Th1 and Th17 cells and its regulation by Th2 cells
McQuillan, K., Lynch, M. A., & Mills, K. H. G. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.01.003 · Cited by 94
“003 F cells are capable of crossing the intact BBB, and infiltrating Th1 and Th17 cells have both been shown to play distinct role in promoting the inflammatory pathology in experimental autoimmune encephalomyelitis, whereas Th2 and Treg cells are protective (Kebir et al., 2007; Kroenke et al., 2008; Mills, 2008; O’Co…”
BackgroundChen, Y., Yang, P., Li, F., & Kijlstra, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018139 · Cited by 97
“lower chamber)6100/(amount of dextran upper chamber) [15].”
Jamshidian, A., Shaygannejad, V., Pourazar, A., Zarkesh‐Esfahani, S. H., & Gharagozloo, M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.06.007 · Cited by 95
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β
Rolla, S., Bardina, V., Mercanti, S. F. D., Quaglino, P., Palma, R. D., Gned, D., Brusa, D., Durelli, L., Novelli, F., & Clerico, M. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a0813-463rr · Cited by 90
“Whereas IL-22 contributes to breaching of the BBB [19], IL-22-deficient mice do not display a reduced phenotype in the EAE model [20].”
BackgroundJurcău, M. C., Jurcău, A., Cristian, A., Hogea, V. O., Diaconu, R. G., & Nunkoo, V. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910535 · Cited by 104
“Finally, activated microglia stimulate astrocytes to release TNF and glutamate and produce more chemokines to recruit leukocytes into the CNS [322].”
BackgroundFeng, Y.-K., Wu, Q.-L., Peng, Y.-W., Liang, F.-Y., You, H.-J., Feng, Y.-W., Li, G., Li, X.-J., Liu, S.-H., Li, Y.-C., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02027-5 · Cited by 87
“Peripheral IL-17A has been reported to disrupt and cross the blood-brain barrier [52].”
BackgroundKleiter, I., Song, J., Lukas, D., Hasan, M., Neumann, B. H., Croxford, A. L., Pedré, X., Hövelmeyer, N., Yogev, N., Mildner, A., et al. (2010) · Brain · doi:10.1093/brain/awq039 · Cited by 97
“…of the Th17 phenotype and its pathogenic role in EAE (Cua et al., 2003; Langrish et al., 2005; Chen et al., 2006) and multiple sclerosis (Kebir et al., 2007), there is ongoing debate whether Th1, Th17, or both subtypes of T lymphocytes are important for the initiation of autoimmune…”
BackgroundWang, X., Deckert, M., Xuân, N. T., Nishanth, G., Just, S., Waisman, A., Naumann, M., & Schlüter, D. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1183-9 · Cited by 98
Wojkowska, D. W., Szpakowski, P., & Glabinski, A. R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051000 · Cited by 91
“This deregulation increases the permeability of the BBB to leukocytes, which is considered to be the first step of MS development [11].”
BackgroundInfluentialThe blood brain barrier in cerebral ischemic injury – Disruption and repair
Zhang, W., Zhu, L. Y., An, C., Wang, R., Yang, L., Yu, W., Li, P., & Gao, Y. (2020) · Brain Hemorrhages · doi:10.1016/j.hest.2019.12.004 · Cited by 98
IL-17A Induces Endothelial Inflammation in Systemic Sclerosis via the ERK Signaling Pathway
Xing, X., Yang, J. Y., Yang, X., Wei, Y., Zhu, L., Gao, D., & Li, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0085032 · Cited by 86
“Other studies have also found that Th17 cells promote the recruitment of additional T cells to vascular endothelial cells in SLE [32,33].”
Jha, M. K., & Trivedi, M. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010233 · Cited by 93
“Increased BBB permeability is associated with infiltration of immune cells, which in turn have been shown to promote depressive behavior [60,68].”
BackgroundGlycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells
Beurel, E., Yeh, W.-I., Michalek, S. M., Harrington, L. E., & Jope, R. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003511 · Cited by 86
Vaccination in Multiple Sclerosis: Friend or Foe?
Zrzavy, T., Kollaritsch, H., Rommer, P. S., Boxberger, N., Loebermann, M., Wimmer, I., Winkelmann, A., & Zettl, U. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01883 · Cited by 85
“IL-17 plays a major role in autoimmunity and MS and may trigger the migration of peripheral lymphocytes into the CNS across the BBB (20, 21) .”
BackgroundInterleukin-17 in post-stroke neurodegeneration
Swardfager, W., Winer, D. A., Herrmann, N., Winer, S., & Lanctôt, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.021 · Cited by 94
Pathological differences between white and grey matter multiple sclerosis lesions
Prins, M., Schul, E., Geurts, J. J. G., van der Valk, P., Drukarch, B., & van Dam, A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12841 · Cited by 96
IL-17 and IL-22 in Cerebrospinal Fluid and Plasma Are Elevated in Guillain-Barré Syndrome
Li, S., Yu, M., Li, H., Zhang, H., & Jiang, Y. (2012) · Mediators of Inflammation · doi:10.1155/2012/260473 · Cited by 85
“Human Th17 cells could disrupt the tight junctions of bloodbrain barrier (BBB) by direct effects of IL-17A and IL-22 on endothelial cells [32].”
BackgroundVeroni, C., Serafini, B., Rosicarelli, B., Fagnani, C., & Aloisi, F. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1049-5 · Cited by 90
MicroRNAs and Multiple Sclerosis
Tüfekçi, K. U., Öner, M. G., Genç, Ş., & Genç, K. (2010) · Autoimmune Diseases · doi:10.4061/2011/807426 · Cited by 86
“Th17 cells produce IL-17A and IL-17F, which are upregulated in chronic lesions [172, 173], and IL-22 which is also involved in MS pathogenesis.”
BackgroundLin, L., Couturier, J. P., Yu, X., Medina, M. Á., Kozinetz, C. A., & Lewis, D. E. (2014) · BMC Immunology · doi:10.1186/s12865-014-0036-1 · Cited by 84
Liu, X., He, F., Pang, R., Zhao, D., Qiu, W., Shan, K., Zhang, J., Lu, Y., Li, Y., & Wang, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.577429 · Cited by 85
IFN‐β regulates CD73 and adenosine expression at the blood–brain barrier
Niemelä, J., Ifergan, I., Yegutkin, G. G., Jalkanen, S., Prat, A., & Airas, L. M. (2008) · European Journal of Immunology · doi:10.1002/eji.200838437 · Cited by 85
Self-citationMultiplexed imaging of immune cells in staged multiple sclerosis lesions by mass cytometry
Ramaglia, V., Sheikh‐Mohamed, S., Legg, K., Park, C., Rojas, O. L., Zandee, S., Fu, F., Ornatsky, O., Swanson, E. C., Pitt, D., et al. (2019) · eLife · doi:10.7554/elife.48051 · Cited by 88
Self-citationChoi, E. Y., Lim, J.-H., Neuwirth, A., Economopoulou, M., Chatzigeorgiou, A., Chung, K.-J., Bittner, S., Lee, S.-H., Langer, H. F., Samus, M., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.146 · Cited by 88
“Moreover, we found increased BBB vascular permeability in Del-1 −/− mice in the course of EAE; this finding could be related to the IL-17-mediated BBB breakdown, published previously 34, 42 .”
Lu, Y., Chen, B., Song, J., Zhen, T., Wang, B., Li, X., Liu, P., Yang, X., Zhang, Q., Xi, X., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222426110 · Cited by 82
“differentiation, which has been shown to be more potent in inducing EAE (29, 30).”
BackgroundKozela, E., Juknat, A., Gao, F., Kaushansky, N., Coppola, G., & Vogel, Z. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0603-x · Cited by 88
“transducer and activator of transcription 3 (STAT3)dependent manner and were defined as autoimmune Th17 phenotype [17–19].”
BackgroundMaternal immune stimulation during pregnancy shapes the immunological phenotype of offspring
Mandal, M., Donnelly, R., Elkabes, S., Zhang, P., Davini, D., David, B. T., & Ponzio, N. M. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.04.012 · Cited by 81
Interleukin-17A Promotes CD8 + T Cell Cytotoxicity To Facilitate West Nile Virus Clearance
Acharya, D., Wang, P., Paul, A. M., Dai, J., Gate, D., Lowery, J. E., Stokić, D. S., Leis, A. A., Flavell, R. A., Town, T., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01529-16 · Cited by 88
“permeability (53), we hypothesized that IL-17A may play a crucial role in the host immune response to WNV infection.”
BackgroundUveitis: Molecular Pathogenesis and Emerging Therapies
Egwuagu, C. E., Alhakeem, S. A., & Mbanefo, E. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.623725 · Cited by 90
“They produce granzyme B that promotes disruption of the BBB and initiate CNS autoimmune diseases including multiple sclerosis and experimental autoimmune encephalomyelitis (EAE) (21).”
BackgroundInfluentialThe good and the bad of neuroinflammation in multiple sclerosis
Naegele, M., & Martinꝉ, R. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00003-0 · Cited by 91
Wieczorek, S., Hoffjan, S., Chan, A., Rey, L. K., Harper, L., Fricke, H., Holle, J. U., Gross, W. L., Epplen, J. T., & Lamprecht, P. (2009) · Genes and Immunity · doi:10.1038/gene.2009.44 · Cited by 82
Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity
Xu, J., Wagoner, G., Douglas, J. C., & Drew, P. D. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008600 · Cited by 83
“However, human IL-22 has been demonstrated to damage the blood brain barrier, suggesting that this cytokine may contribute to the development of MS [21].”
BackgroundRORC2: The master of human Th17 cell programming
Unutmaz, D. (2009) · European Journal of Immunology · doi:10.1002/eji.200939540 · Cited by 84
Interleukin-23 and Th17 Cells in the Control of Gut Inflammation
Monteleone, I., Pallone, F., & Monteleone, G. (2009) · Mediators of Inflammation · doi:10.1155/2009/297645 · Cited by 95
Yanuck, S. F. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00712 · Cited by 94
“org Infection (73, 114, 115), stress and depression (6, 116–118), altered microbiota (120) and other forms of digestive dysregulation (119–122), dysglycemia, insulin resistance, and obesity (123–126), tissue hypoxia [80, 127 (review), 128, 129], poor diet (130–134), lack of exercise (135–139), environmental or other t…”
Wüst, S., Tischner, D., John, M., Tuckermann, J. P., Menzfeld, C., Hanisch, U., van den Brandt, J., Lühder, F., & Reichardt, H. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008202 · Cited by 80
“This is in line with the previously proposed model that Th17 rather than Th1 cells are central to the development and pathogenesis of EAE [31,32] as well as MS [37].”
ResultNeuromyelitis optica and opticospinal multiple sclerosis: Mechanisms and pathogenesis
Kira, J. (2010) · Pathophysiology · doi:10.1016/j.pathophys.2010.04.008 · Cited by 85
Metadata
- Authors
- Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A.
- Affiliations
- University of Zurich (CH)
- Hôpital Notre-Dame (CA)
- University of Alberta (CA)
- Corresponding author
- Prat, Alexandre
- Venue
- Nature Medicine
- Published
- 2007-09-09
- Volume
- 13
- Issue
- 10
- Pages
- 1173-1175
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC5114125
- OpenAlex
- W1998000193
- Semantic Scholar
- d0c491686d390e0dfdffedd4e32222d5b6065fd7
- Cited by
- 1,759
- References
- 14
- Citations by year
- 2026: 69 · 2025: 78 · 2024: 85 · 2023: 116 · 2022: 104 · 2021: 86 · 2020: 96 · 2019: 87 · 2018: 98 · 2017: 98 · 2016: 90 · 2015: 94 · 2014: 97 · 2013: 106 · 2012: 86
- FWCI
- 54.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- Canadian Institutes of Health Research (79785_1)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- Th17 cells, blood-brain barrier, endothelial cells, IL-17, IL-22, tight junctions, multiple sclerosis, neuroinflammation, lymphocyte transmigration, granzyme B
- MeSH terms
- Blood-Brain Barrier, Cell Membrane Permeability, Cell Movement, Cells, Cultured, Central Nervous System, Dose-Response Relationship, Drug, Endothelium, Vascular, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Multiple Sclerosis, CD4-Positive T-Lymphocytes, Case-Control Studies, Receptors, Interleukin, Tight Junctions, Interleukin-17, Endothelial Cells, Granzymes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.